Skip to main content



Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of
the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,
will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource
adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection
at the point of care patient level.

Call for proposal

See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1


Abogade 15
8200 Aarhus N
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000